SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues	$ 1,529	$ 1,511
Cost of Revenues:
Material and Labor	1,025	974
Other cost of revenues	212	245
Total Cost of Revenues	1,237	1,219
Research and development (R&D)
Share based compensation	2,729	2,618
Total Research and development	4,059	2,625
Selling and marketing (S&M)
Total Selling and marketing	2,750	1,237
General and administrative (G&A)
Total General and administrative	4,943	3,844
Financial Income, net;	294	382
Segment net Loss	(11,166)	(7,032)
Research and Development Expense [Member]
Research and development (R&D)
Payroll and Benefits	855	683
Share based compensation	668	468
Clinical trials	1,160	784
Other R&D	1,376	690
Selling and Marketing Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,979	822
Share based compensation	217	250
Selling and marketing (S&M)
Other S&M	554	165
General and Administrative Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,676	915
Share based compensation	1,779	1,784
General and administrative (G&A)
Other G&A	$ 1,488	$ 1,145